Key result
Mutations hindering the formation or reducing the efficiency of the GPIHBP1-LPL complex are central to the onset of chylomicronemia.
Why the study?
Mutations hindering the formation or reducing the efficiency of the GPIHBP1-LPL complex are central to chylomicronemia, motivating an examination of this interaction and treatment advancements.
This review highlights the critical role of the GPIHBP1-LPL complex in lipid metabolism and its implications for the pathogenesis and treatment of chylomicronemia.
May inform genetic diagnostics in chylomicronemia; leaves open prospective validation and therapeutic translation.
GPIHBP1 is a protein found in the endothelial cells of capillaries that is anchored by glycosylphosphatidylinositol and binds to high-density lipoproteins. GPIHBP1 attaches to lipoprotein lipase (LPL), subsequently carrying the enzyme and anchoring it to the capillary lumen. Enabling lipid metabolism is essential for the marginalization of lipoproteins alongside capillaries. Studies underscore the significance of GPIHBP1 in transporting, stabilizing, and aiding in the marginalization of LPL. The intricate interplay between GPIHBP1 and LPL has provided novel insights into chylomicronemia in recent years. Mutations hindering the formation or reducing the efficiency of the GPIHBP1-LPL complex are central to the onset of chylomicronemia. This review delves into the structural nuances of the GPIHBP1-LPL interaction, the consequences of mutations in the complex leading to chylomicronemia, and cutting-edge advancements in chylomicronemia treatment.
No takes yet. Share an insight, caveat, or question.
Jiang et al. (2023) conducted a review in Chylomicronemia. GPIHBP1-LPL complex mutations was evaluated. Mutations hindering the formation or reducing the efficiency of the GPIHBP1-LPL complex are central to the onset of chylomicronemia.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: